MedTrace Logo

Liver Injury by Statins in Patients With History of Hepatitis B Virus Infection

NCT02808299 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2016-06-21

No results posted yet for this study

Summary

The purpose of this study is to investigate the incidence of liver injury by statins in coronary heart disease (CHD) patients with history of hepatitis B virus (HBV) infection.

Conditions

  • Liver Injury
  • Hepatitis B Virus Infection History

Interventions

OTHER

HBV infection history

HBV infection history or HBV carriers

Sponsors & Collaborators

  • The First Affiliated Hospital with Nanjing Medical University

    lead OTHER

Principal Investigators

  • Zhijian Yang, Doctor · First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02808299 on ClinicalTrials.gov